Overview
Takashi Seto practices practicing medicine in Fukuoka, Japan.
Mr. Seto is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, Thymic Epithelial Tumor, and Tissue Biopsy.
He is actively involved in clinical research, co-authoring 234 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Takashi Seto
Is Takashi Seto a top-rated expert for Non-Small Cell Lung Cancer (NSCLC)?
MediFind is an objective health platform that identifies experts based on real-world data. Takashi Seto is classified as an Elite expert for Non-Small Cell Lung Cancer (NSCLC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Takashi Seto participate in research or clinical trials?
Yes. Takashi Seto has published 234 articles and abstracts on conditions like Non-Small Cell Lung Cancer (NSCLC). You can view a list of Takashi Seto's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- EGFR Positive Lung Cancer
- Lung CancerMr. Seto isElite. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- Distinguished
- Febrile NeutropeniaMr. Seto isDistinguished. Learn about Febrile Neutropenia.
- Lung AdenocarcinomaMr. Seto isDistinguished. Learn about Lung Adenocarcinoma.
- Small Cell Lung Cancer (SCLC)Mr. Seto isDistinguished. Learn about Small Cell Lung Cancer (SCLC).
- Thymic Epithelial TumorMr. Seto isDistinguished. Learn about Thymic Epithelial Tumor.
- Advanced
- AgranulocytosisMr. Seto isAdvanced. Learn about Agranulocytosis.
- Tissue BiopsyMr. Seto isAdvanced. Learn about Tissue Biopsy.
- Experienced
- Adult Soft Tissue SarcomaMr. Seto isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Brain TumorMr. Seto isExperienced. Learn about Brain Tumor.
- Breast CancerMr. Seto isExperienced. Learn about Breast Cancer.
- Cerebral Cavernous MalformationMr. Seto isExperienced. Learn about Cerebral Cavernous Malformation.
- DiarrheaMr. Seto isExperienced. Learn about Diarrhea.
- EmpyemaMr. Seto isExperienced. Learn about Empyema.
- EsophagitisMr. Seto isExperienced. Learn about Esophagitis.
- Familial HypertriglyceridemiaMr. Seto isExperienced. Learn about Familial Hypertriglyceridemia.
- High CholesterolMr. Seto isExperienced. Learn about High Cholesterol.
- HypertensionMr. Seto isExperienced. Learn about Hypertension.
- Low Sodium LevelMr. Seto isExperienced. Learn about Low Sodium Level.
- Lung MetastasesMr. Seto isExperienced. Learn about Lung Metastases.
- Lung NodulesMr. Seto isExperienced. Learn about Lung Nodules.
- Lymphofollicular HyperplasiaMr. Seto isExperienced. Learn about Lymphofollicular Hyperplasia.
- Mediastinal TumorMr. Seto isExperienced. Learn about Mediastinal Tumor.
- MesotheliomaMr. Seto isExperienced. Learn about Mesothelioma.
- Metastatic Brain TumorMr. Seto isExperienced. Learn about Metastatic Brain Tumor.
- ParonychiaMr. Seto isExperienced. Learn about Paronychia.
- Pleural EffusionMr. Seto isExperienced. Learn about Pleural Effusion.
- PneumoniaMr. Seto isExperienced. Learn about Pneumonia.
- Squamous Cell Lung CarcinomaMr. Seto isExperienced. Learn about Squamous Cell Lung Carcinoma.